Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Author's Avatar
Feb 28, 2023

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on February 28, 2023.